Jesús
San Miguel Izquierdo
Consultor Investigador
Ben-Gurion University of the Negev
Beerseba, IsraelPublicaciones en colaboración con investigadores/as de Ben-Gurion University of the Negev (4)
2023
2020
-
Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study
Leukemia, Vol. 34, Núm. 7, pp. 1875-1884
-
Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
Blood Cancer Journal, Vol. 10, Núm. 11
2019
-
Insights on Multiple Myeloma Treatment Strategies
HemaSphere, Vol. 3, Núm. 1